EFGCP Focuses on Implementing Risk-Based Monitoring
EFGCP is organizing an interactive workshop intended to develop practical strategies and approaches for risk management and risk-based monitoring in clinical trials
The European Forum for Good Clinical Practice (EFGCP) is organizing an interactive workshop intended to develop practical strategies and approaches for risk management and risk-based monitoring in clinical trials. The event, to be held on June 16 and 17 at University College London (UCL), UK, is being put together by the EFGCP’s Education Working Party in association with the Alliance for Clinical Research Excellence and Safety (ACRES), European Organization for Research and Treatment of Cancer (EORTC), and UCL.
“Up to now discussions on risk management have been mainly theoretical and the practicalities of ‘how to’ have not been defined. Yet nobody is sure how much is actually ‘enough’ and how much is too little,” stated the organizers. “Research organizations are starting to create their approaches to risk assessment and risk-based monitoring and yet there are still questions which need to be addressed, especially on how to define, justify and ‘validate’ what is critical to patients' safety, integrity and rights, and data integrity.”
The workshop has been developed in collaboration with thought leaders from health authorities, industry, CROs, academia and patients’ representatives, according to EFGCP. At the end of the meeting, a roundtable discussion with regulators is planned to decide whether the approaches developed during the workshop are likely to be acceptable. Those delegates who are more knowledgeable on risk assessment and management will drive during the workshop the discussion based on their ‘hands on’ experience, others that are less familiar with these concepts can adopt a more observational role.
Symbravo Outperforms Oral CGRP Inhibitors in Phase III Trial, With Faster, Sustained Migraine Relief
February 24th 2025Data from the Phase III EMERGE trial show treatment with Symbravo provided more rapid and sustained migraine relief with improved quality of life in patients who previously had an inadequate response to CGRP treatments.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
The Importance of Real-World Evidence in Medical Research and Drug Development
February 18th 2025The ongoing evolution of real-world evidence from a novel concept to a cornerstone of modern medical research signifies its growing importance and vast potential to improve personalized medicine, overall healthcare outcomes, and eventually democratization of scientific facts by general accessibility.
